184 related articles for article (PubMed ID: 15049001)
1. Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer.
Zhong L; Peng X; Hidalgo GE; Doherty DE; Stromberg AJ; Hirschowitz EA
Proteomics; 2004 Apr; 4(4):1216-25. PubMed ID: 15049001
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies as potential biomarkers for breast cancer.
Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
[TBL] [Abstract][Full Text] [Related]
3. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
[TBL] [Abstract][Full Text] [Related]
4. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
Zhong L; Coe SP; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
J Thorac Oncol; 2006 Jul; 1(6):513-9. PubMed ID: 17409910
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients.
Zhong L; Peng X; Hidalgo GE; Doherty DE; Stromberg AJ; Hirschowitz EA
Cancer Detect Prev; 2003; 27(4):285-90. PubMed ID: 12893076
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.
Tong YQ; Zhang ZJ; Liu B; Huang J; Liu H; Liu Y; Guo FJ; Zhou GH; Xie PL; Li YH; Zuo CH; Hu JY; Li GC
Proteomics; 2008 Aug; 8(15):3185-93. PubMed ID: 18654982
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-p53 antibodies in lung cancer: comparison with established tumor markers.
Cioffi M; Vietri MT; Gazzerro P; Magnetta R; D'Auria A; Durante A; Nola E; Puca GA; Molinari AM
Lung Cancer; 2001; 33(2-3):163-9. PubMed ID: 11551411
[TBL] [Abstract][Full Text] [Related]
8. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer.
Khattar NH; Coe-Atkinson SP; Stromberg AJ; Jett JR; Hirschowitz EA
Cancer Biol Ther; 2010 Aug; 10(3):267-72. PubMed ID: 20543565
[TBL] [Abstract][Full Text] [Related]
10. Using protein microarray as a diagnostic assay for non-small cell lung cancer.
Zhong L; Hidalgo GE; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
Am J Respir Crit Care Med; 2005 Nov; 172(10):1308-14. PubMed ID: 16109979
[TBL] [Abstract][Full Text] [Related]
11. Optimized serological isolation of lung-cancer-associated antigens from a yeast surface-expressed cDNA library.
Kim MS; Choi HY; Choi YS; Kim J; Kim YS
J Microbiol Biotechnol; 2007 Jun; 17(6):993-1001. PubMed ID: 18050918
[TBL] [Abstract][Full Text] [Related]
12. SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.
Krause P; Türeci O; Micke P; Buhl R; Huber C; Sahin U
J Immunol Methods; 2003 Dec; 283(1-2):261-7. PubMed ID: 14659917
[TBL] [Abstract][Full Text] [Related]
13. Serum antibodies to retinal antigens in lung cancer and sarcoidosis.
Jankowska R; Witkowska D; Porebska I; Kuropatwa M; Kurowska E; Gorczyca WA
Pathobiology; 2004; 71(6):323-8. PubMed ID: 15627843
[TBL] [Abstract][Full Text] [Related]
14. Serum tumor markers in non-small cell lung cancer. A comparative analysis.
Margolis ML; Hyzy JB; Schenken LL; Schepart BS
Cancer; 1994 Feb; 73(3):605-9. PubMed ID: 8299082
[TBL] [Abstract][Full Text] [Related]
15. Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.
Yao Y; Fan Y; Wu J; Wan H; Wang J; Lam S; Lam WL; Girard L; Gazdar AF; Wu Z; Zhou Q
Biochem Biophys Res Commun; 2012 Jul; 423(3):613-9. PubMed ID: 22713465
[TBL] [Abstract][Full Text] [Related]
16. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
[TBL] [Abstract][Full Text] [Related]
17. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Gnjatic S; Wheeler C; Ebner M; Ritter E; Murray A; Altorki NK; Ferrara CA; Hepburne-Scott H; Joyce S; Koopman J; McAndrew MB; Workman N; Ritter G; Fallon R; Old LJ
J Immunol Methods; 2009 Feb; 341(1-2):50-8. PubMed ID: 19041653
[TBL] [Abstract][Full Text] [Related]
18. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
[TBL] [Abstract][Full Text] [Related]
19. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
[TBL] [Abstract][Full Text] [Related]
20. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
